Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-α2a/ribavirin therapy

Journal of Hepatology

Volumn 48, Issue 6, 2008, Pages 932-938

  Pugnale, Paolo ^a   Herrmann, Eva ^b   Neumann, Avidan U ^c   Pawlotsky, Jean Michel ^d   Schalm, Solko W ^e   Ferrari, Carlo ^f   Homburger, Yonit ^c   Zeuzem, Stefan ^g   Negro, Francesco ^a,h  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b SAARLAND UNIVERSITY   (Germany)

^c BAR ILAN UNIVERSITY   (Israel)

^d HENRI MONDOR HOSPITAL   (France)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY HOSPITAL OF PARMA   (Italy)

^g UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^h UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Antiviral response; Hepatitis C virus; PBMC; Viral kinetics

Indexed keywords

PEGINTERFERON; PEGINTERFERON ALPHA2A; RIBAVIRIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KINETICS; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS REPLICATION;

ADULT; AGED; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PLASMA; RIBAVIRIN; RNA, VIRAL; VIRAL LOAD; VIRUS REPLICATION;

EID: 43149118775     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.02.018     Document Type: Article

References (26)

1. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 (2001) 958-965
2. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales Jr. F.L., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347 (2002) 975-982
3. Hadziyannis S.J., Sette Jr. H., Morgan T.R., Balan V., Diago M., Marcellin P., et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 140 (2004) 346-355
4. Blackard J.T., Kemmer N., and Sherman K.E. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 44 (2006) 15-22
5. Watkins-Riedel T., Ferenci P., Steindl-Munda P., Gschwantler M., Mueller C., and Woegerbauer M. Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis. Clin Infect Dis 39 (2004) 1754-1760
6. Pham T.N., MacParland S.A., Mulrooney P.M., Cooksley H., Naoumov N.V., and Michalak T.I. Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C. J Virol 78 (2004) 5867-5874
7. Asahina Y., Izumi N., Uchihara M., Noguchi O., Tsuchiya K., Hamano K., et al. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta. Hepatology 34 (2001) 377-384
8. Pugnale P., Latorre P., Rossi C., Crovatto K., Pazienza V., De Gottardi A., et al. Real-time multiplex PCR assay to quantify hepatitis C virus RNA in peripheral blood mononuclear cells. J Virol Methods 133 (2006) 195-204
9. Dahari H., Feliu A., Garcia-Retortillo M., Forns X., and Neumann A.U. Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation. J Hepatol 42 (2005) 491-498
10. Zeuzem S., Pawlotsky J.M., Lukasiewicz E., von Wagner M., Goulis I., Lurie Y., et al. International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C. J Hepatol 43 (2005) 250-257
11. Perelson A.S., Herrmann E., Micol F., and Zeuzem S. New kinetic models for the hepatitis C virus. Hepatology 42 (2005) 749-754
12. Guedj J., Thiebaut R., and Commenges D. Maximum likelihood estimation in dynamical models of HIV. Biometrics 63 (2007) 1198-1206
13. Blackard J.T., Hiasa Y., Smeaton L., Jamieson D.J., Rodriguez I., Mayer K.H., et al. Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection. J Infect Dis 195 (2007) 1765-1773
14. Laskus T., Radkowski M., Wang L.F., Cianciara J., Vargas H., and Rakela J. Hepatitis C virus negative strand RNA is not detected in peripheral blood mononuclear cells and viral sequences are identical to those in serum: a case against extrahepatic replication. J Gen Virol 78 (1997) 2747-2750
15. Lerat H., Berby F., Trabaud M.A., Vidalin O., Major M., Trepo C., et al. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 97 (1996) 845-851
16. Boisvert J., He X.S., Cheung R., Keeffe E.B., Wright T., and Greenberg H.B. Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis 184 (2001) 827-835
17. Moldvay J., Deny P., Pol S., Brechot C., and Lamas E. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells of infected patients by in situ hybridization. Blood 83 (1994) 269-273
18. Muratori L., Gibellini D., Lenzi M., Cataleta M., Muratori P., Morelli M.C., et al. Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood 88 (1996) 2768-2774
19. Lanford R.E., Sureau C., Jacob J.R., White R., and Fuerst T.R. Demonstration of in vitro infection of chimpanzee hepatocytes with hepatitis C virus using strand-specific RT/PCR. Virology 202 (1994) 606-614
20. Yuki N., Matsumoto S., Tadokoro K., Mochizuki K., Kato M., and Yamaguchi T. Significance of liver negative-strand HCV RNA quantitation in chronic hepatitis C. J Hepatol 44 (2006) 302-309
21. Bronowicki J.P., Loriot M.A., Thiers V., Grignon Y., Zignego A.L., and Brechot C. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology 28 (1998) 211-218
22. Laskus T., Operskalski E.A., Radkowski M., Wilkinson J., Mack W.J., deGiacomo M., et al. Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women. J Infect Dis 195 (2007) 124-133
23. Radkowski M., Gallegos-Orozco J.F., Jablonska J., Colby T.V., Walewska-Zielecka B., Kubicka J., et al. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41 (2005) 106-114
24. Taliani G., Badolato C., Lecce R., Poliandri G., Bozza A., Duca F., et al. Hepatitis C virus RNA in peripheral blood mononuclear cells: relation with response to interferon treatment. J Med Virol 47 (1995) 16-22
25. Gong G.Z., Lai L.Y., Jiang Y.F., He Y., and Su X.S. HCV replication in PBMC and its influence on interferon therapy. World J Gastroenterol 9 (2003) 291-294
26. Neumann A.U., Lam N.P., Dahari H., Gretch D.R., Wiley T.E., Layden T.J., et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282 (1998) 103-107